Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1TP53 Y220C Mutation 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pulmonary Embolism 1Prostatic Neoplasms, Castration-Resistant 1Peripheral Nervous System Diseases 1Neoplasms 1Liver Cirrhosis 1Leiomyosarcoma 1Healthy Participants 1Healthy Adult Participants 1Endometrial Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1Advanced Solid Malignancies 1

Interventions

tremelimumab 1epigallocatechin gallate 1durvalumab 1babao dan 1Urination 1Standard of Care 1Rosuvastatin Calcium 1Preoperative Exercise 1Furosemide 1Erlotinib Hydrochloride 1Digoxin 1Diagnostic Imaging 1Control Groups 1Cannabidiol 1Breathing Exercises 1Breath Tests 1Blood Specimen Collection 1Aspirin 1Anti-HIV Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Cirrhosis × Rosuvastatin Calcium × 1 year × Clear all
NCT05741372 2026-01-13

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Boehringer Ingelheim

Phase NA Completed
28 enrolled 15 charts

Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡